<DOC>
	<DOCNO>NCT02145351</DOCNO>
	<brief_summary>Determine impact restore normal heart rate response exercise daily activity patient heart failure preserve ejection fraction ( HFpEF ) chronotropic incompetence ( CI ) .</brief_summary>
	<brief_title>Efficacy Study Pacemakers Treat Slow Heart Rate Patients With Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Heart Failure , Diastolic</mesh_term>
	<criteria>Inclusion Criteria 1 . Age &gt; 18 year able provide inform consent enroll trial , consent legal guardian power attorney . 2 . Previous clinical diagnosis HF current NYHA Class IIIII symptoms 3 . At least one following : Hospitalization decompensated HF , Acute treatment HF intravenous loop diuretic hemofiltration , Chronic treatment loop diuretic control HF symptom + leave atrial enlargement echocardiography 4 . Left ventricular EF ≥50 % within 12 month clinical stability 5 . Stable cardiac medical therapy ≥30 day 6 . Sinus rhythm 7 . Chronotropic incompetence recent ( within 6 month ) clinical screening exercise test , define heart rate reserve ( HRR ) &lt; 0.80 8 . Meet screen criterion clinicallyperformed cardiopulmonary exercise test within 12 month . Peak VO2 ≤60 % age/sexadjusted normal value + peak respiratory exchange ratio ( RER ) ≥1.05 One following : NTproBNP ≥400 pg/mL NTproBNP &lt; 400 pg/mL , rest PCWP &gt; 20 mmHg and/or &gt; 25 mmHg exercise Exclusion Criteria 1 . Inability exercise , noncardiac condition precludes exercise test 2 . Any contraindication pacemaker system 3 . Noncardiac condition limit life expectancy le one year 4 . Significant leave sided structural valve disease ( &gt; mild stenosis , &gt; moderate regurgitation ) 5 . Hypertrophic cardiomyopathy 6 . Infiltrative inflammatory myocardial disease ( amyloid , sarcoid ) 7 . Pericardial disease 8 . Nongroup 2 pulmonary arterial hypertension 9 . Chronic stable exertional angina 10 . Acute coronary syndrome revascularization within 60 day 11 . Other clinically important cause dyspnea 12 . Atrial fibrillation 13 . PR interval &gt; 210 msec 14 . Resting heart rate ( HR ) &gt; 100 bpm 15 . A history reduce ejection fraction ( EF &lt; 50 % ) 16 . Advanced chronic kidney disease ( GFR &lt; 20 ml/min/1.73m2 modify MDRD equation ) 17 . Women child bear potential without negative pregnancy test effective contraception 18 . Severe anemia ( Hemoglobin &lt; 10 g/dL ) 19 . Severe hepatic disease 20 . Complex congenital heart disease 21 . Listed cardiac transplantation 22 . Other class I indications pace</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>HFpEF</keyword>
	<keyword>Heart failure</keyword>
	<keyword>Heart failure preserve ejection fraction</keyword>
	<keyword>Chronotropic incompetence</keyword>
</DOC>